NCT00328497 2010-03-10
A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
CASI Pharmaceuticals, Inc.
Phase 2 Completed
Clinical Trials
4 trialsNCT00592579 2009-02-26
A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
CASI Pharmaceuticals, Inc.
Phase 2 Completed
NCT00306618 2008-12-10
Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
CASI Pharmaceuticals, Inc.
Phase 2 Completed
NCT00481455 2008-11-25
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
CASI Pharmaceuticals, Inc.
Phase 2 Completed